about
Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes.Differences in Red Blood Cell Indices Do Not Explain Racial Disparity in Hemoglobin A1c in Children with Type 1 DiabetesRacial disparity in A1C independent of mean blood glucose in children with type 1 diabetes.Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic controlSkin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trialAssociation between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.Economic burden of hypoglycemia in patients with Type 2 diabetes.Biological variation and hemoglobin A1c: relevance to diabetes management and complications.Racial differences in neighborhood disadvantage, inflammation and metabolic control in black and white pediatric type 1 diabetes patients.Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.Comment on: Wilson et al. Persistence of individual variations in glycated hemoglobin: analysis of data from the juvenile diabetes research foundation continuous glucose monitoring randomized trial. Diabetes Care 2011;34:1315-1317.Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients.Characterization of S-glutathionyl hemoglobin in homozygous sickle cell disease.Two-dimensional analysis of glycated hemoglobin heterogeneity in pediatric type 1 diabetes patients.Association between Helicobacter felis-induced gastritis and elevated glycated hemoglobin levels in a mouse model of type 1 diabetes.High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.Diagnosis and characterization of Hb C/Hb Iowa: a rare but easily misidentified compound heterozygous condition.Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes.Advanced glycation end-products in sickle cell anaemia.Advanced glycation endproducts in children with diabetes.Analysis of murine S-glutathionyl hemoglobins and beta globin haplotype by dynamic capillary isoelectric focusing.A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes.Caveats regarding the use of HbA1c for prediction of mean blood glucose.Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial: Diabetes 56:1913-1921, 2007.Effect of long-term Helicobacter felis infection in a mouse model of streptozotocin-induced diabetes.Tracking of blood pressure and its impact on graft function in pediatric renal transplant patients.Simultaneous analysis of reduced glutathione and glutathione disulfide by capillary zone electrophoresis.Skin intrinsic fluorescence is associated with hemoglobin A1c and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care 2011;34:1816–1820.Capillary isoelectric focusing of hemoglobin variants in the pediatric clinical laboratoryPredictors of glycemic control in children with type 1 diabetes: the importance of raceLongitudinal analysis of plasma cytomegalovirus DNA in a child with Crohn's disease and cytomegalovirus gastroenteritisAcute and chronic inflammation in pediatric patients receiving hemodialysisDNA sequence of Hb IowaCharacterization of unstable hemoglobin A1c complexes by dynamic capillary isoelectric focusingMetrics for monitoring glycemic control
P50
Q33602143-F1BF4C2E-48AC-4EE8-A42D-37868A6B2418Q33688393-AB93D04C-F4ED-4808-A8A1-475C0E4F288AQ33804588-2E9AE4B9-2AAA-401E-B10F-40E2311C33FCQ33932621-5E14757C-5564-4CED-9CEE-A49074989DC2Q35123432-9BE6EFA7-3EB8-4BC2-8E9E-6C022443883EQ35630701-2BAD7F79-A5CC-40EF-ADF1-737AC2429CCAQ35680892-67B58C59-0B12-4E60-A80A-24A02952CB5BQ37978905-68266CE9-EC3C-4240-8A75-B98C33025688Q38129464-1567C22D-C575-445F-B96D-976617F7B20EQ38919030-45A66B27-3DA2-4FD1-8BB6-B46586C1D473Q42769132-FEC36AE3-532F-45A0-9EE4-13801966C32FQ42872267-638F8CE7-8565-4503-A71B-19EEAA45277EQ43188631-81F5943F-A820-48DF-B3D6-9AA058F13015Q43255307-C1F52D07-8123-4EA8-9B98-1AF7D63A0D4FQ43832605-1F109E55-E94A-48E4-8908-5262A10C4BD6Q43981096-2ECC9DF8-D160-438B-B108-773A83436854Q44117447-7AFB10FB-016C-4110-92BC-2451455C727DQ44791401-EC6F5204-BEE9-43AD-A053-9CCE186586DCQ44909487-376056A0-AFE7-48EA-AB9C-CCAE96B3F92CQ45192194-30C0268D-1685-4663-A40C-7D364DB76CE9Q45833641-5D2C8295-A297-45CE-9AFD-1E77FDC41F52Q45958242-B5FB4973-09F8-40A7-8735-A7475E53FCD1Q46579589-8559C64F-6700-4AE2-8D48-08E8B8A1121AQ46720448-E70A8DBC-FEB6-417E-B93E-4A669CE6580EQ46786150-AAB70DD6-49EC-4630-B6CE-E7B29A7331E9Q46816065-664AB37D-DFF3-4EB7-BCFA-51183A75F2B0Q48897657-EC3B0098-AA61-4DE7-B4EF-5E58F88895AAQ50482268-706BC92D-4C83-4992-81A6-96C2E54A1AAAQ55501943-B5D59D04-2D64-40EE-B19F-611CF5DA350BQ73885093-109D82B8-8607-4051-A484-FA50178FA356Q74223813-9B7D5E9F-6363-435E-AB2E-4B4F69383F43Q77751291-96EB665B-8C87-4175-9004-4C5CE408EC17Q79292151-7054BA82-E7BE-42F5-9283-A2418721487DQ80855349-C1EC2383-E80C-4C32-A353-05B1D1BDDE68Q83523324-2A214684-07DD-4CE5-8D37-61A020AC8C62Q84411159-7C11F9E8-FD68-45D3-BF64-C9EAA3EF21E5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James M. Hempe
@ast
James M. Hempe
@en
James M. Hempe
@es
James M. Hempe
@nl
James M. Hempe
@sl
type
label
James M. Hempe
@ast
James M. Hempe
@en
James M. Hempe
@es
James M. Hempe
@nl
James M. Hempe
@sl
prefLabel
James M. Hempe
@ast
James M. Hempe
@en
James M. Hempe
@es
James M. Hempe
@nl
James M. Hempe
@sl
P106
P1153
7004236912
P21
P31
P496
0000-0001-7038-7499